Distinguished Lecturer Seminar Series
© dkfz.de
Upcoming Speakers
Elizabeth Henske - Brigham and Women's Hospital
© dkfz.de
Date: 21.11.2024
Time: 11:00
Location: DKFZ Main Lecture Hall
Host: A. Teleman
Titel: Tuberous Sclerosis, TFEB, and the Target of Rapamycin (mTOR): New Connections
About:
Elizabeth (Lisa) Petri Henske is the Director of the Center for LAM Research and Clinical Care at Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School, an Associate Member of the Broad Institute of MIT and Harvard, and a practicing medical oncologist at the Dana-Farber Cancer Institute. LAM (lymphangioleiomyomatosis) is a destructive lung disease of women leading to lung collapse and respiratory failure, often with rapid progression during pregnancy. Dr. Henske's laboratory made the pivotal discovery that LAM is caused by mutations in the tuberous sclerosis complex 2 (TSC2) gene, leading to clinical trials demonstrating efficacy of mTORC1 inhibitors. Her research laboratory is focused on the cellular, metabolic, and immunologic mechanisms underlying the pathogenesis of tuberous sclerosis complex (TSC) and LAM, supported by multiple grants from the National Institutes of Health. She is a member of the American Society for Clinical Investigation and has received awards for her research from the Tuberous Sclerosis Alliance, The LAM Foundation, the American Thoracic Society, and the Society for Women's Health Research (the Medtronic Prize). EHenske@BWH.Harvard.edu
Nicola Aceto - ETH Zürich
Date: 13.01.2025
Time: 15:00
Location: BioQuant Main Lecture Hall
Host: S. Schölch
Titel: Circulating Tumor Cells
About:
Nicola Aceto is Full Professor of Molecular Oncology at the ETH Zurich. Prior to joining ETH, he has been Swiss National Science Foundation Assistant Professor of Oncology at the University of Basel. The Aceto lab contributed to key discoveries in the metastasis field, including investigations of the biology and vulnerabilities of circulating tumor cells and their clusters, some of which already translated into clinical trials for patients with metastatic breast cancer. Nicola completed his training at the Friedrich Miescher Institute (FMI) in Basel, Switzerland, at the Massachusetts General Hospital Cancer Center and Harvard Medical School, and at the Broad Institute of MIT and Harvard in Boston, USA. To date, Nicola received three ERC Grants (StG 2015, PoC 2018, CoG 2020) and numerous awards related to his work on circulating tumor cells, including the Swiss Science Prize Latsis for Groundbreaking Cancer Research, the EACR Translational Cancer Research Award, the Robert Wenner Award from the Swiss Cancer League and the Friedrich Miescher Award for Outstanding Achievements in Biochemistry. He is an inventor in several patent applications related to the diagnosis and treatment of cancer, advisor for several companies with an interest in liquid biopsy, and co-founder of an ETH Spinoff biotech company dedicated to the development of new cancer medicines.
Massimiliano Pagani - University of Milan
Date: 04.02.2025
Time: 11:00
Location: Main Auditorium
Host: D. Odom
Titel: to be announced
Prof. Richard Vile
Date: 27.03.2025
Time: 11:00
Location: Main Auditorium
Host: D. Nettelbeck
Titel: to be announced
Filipe Pereira - Lund University
Date: 04.04.2025
Time: tbd
Location: Main Auditorium
Host: M. Mall
Titel: to be announced
Muzz Haniffa - Newcastle University
Date: postponed tbd
Time: tbd
Location: DKFZ Main Lecture Hall
Host: D. Lipka
Titel: to be announced
George M. Church - Harvard Medical School
Date: tbd
Time: tbd
Location: tbd
Host: J. Hoheisel
Titel: to be announced
Jonas Frisén - Karolinska Institute
Date: tbd- 2024/5
Location: DKFZ Main Lecture Hall
Host: E. Aurélie
Titel: to be announced
Past Speakers
Raghu Kalluri - MD Anderson
September 30th, .2024
Andy Minn - University of Pennsylvania
July 8th, .2024
Tracy McGaha - Princess Margaret Cancer Centre, University of Toronto
June 20th ,2024
Dana Pe`er - Sloan Kettering Institute
April 25th, 2024
Yang Shi - Ludwig Institute for Cancer Research
December 1st, 2023
Rebecca Fitzgerald - University of Cambridge
November 14th, 2023
Larissa Nekhlyudov - Brigham and Women’s Hospital
October 20th, 2023
Pedro A. Lazo-Zibikowski - Centro de Investigación del Cáncer
September 21st, 2023
Howard Chang - Stanford University
July 7th, 2023
Chen Dong - University of Texas
April 3rd, 2023
Frederick W. Alt - Harvard Medical School
March 16th, 2023
Marcus Conrad - Helmholtz Zentrum München
February 24th, 2023
E. Antonio Chiocca - Brigham and Women's Hospital
January 27th, 2023
Kristian Helin - Institute of Cancer Research
October 4th, 2022
Barbara Treutlein - ETH Zürich
June 10th, 2022
Zena Werb, University of California San Francisco
March 10th, 2020
Prof. Alexander Meissner, Max Planck
January 2020
Prof. Shelley Tworoger, Harvard Medical School
October 2019
Prof. Richard A. Young, Whitehead Institut
October 2019
Prof. Kamil Ugurbil, University of Minnesota, 21.03.2019
March 2019
Peter Walter, UCSF
January 2019
Tony Green, University of Cambridge
November 2018
Johannes Zuber - IMP
April 19, 2018
Jeffrey Rathmell - Vanderbilt University Medical Center
February 22, 2018
Iñaki Martin-Subero - IDIBAPS
January 18, 2018
(at)epigenetics Workshop
Richard Gilbertson - CRUKCI
October, 26, 2017
Ali Shilatifard - Northwestern
September 29, 2017
Dirk Trauner - NYU
July 13, 2017
Karen Vousden - CRUK
May 22, 2017
Kari Alitalo - Institute of Biomedicine Biomedicum
March 23, 2017
Klaus Rajewsky - MDC
March 16, 2017
Ruud Delwel - Erasmus MC
February 06, 2017
Gary Felsenfeld - February 03, 2017
Erwin Böttinger - BIH
December 13, 2016
Min Li - The University of Oklahoma Health Sciences Center
October 20, 2016
Thomas Boehm - Max-Planck-Institut für Immunbiologie
September Friday 30, 2016
Scott Lowe - Memorial Sloan Kettering Cancer Center
September Thursday 22, 2016
Diane Mathis - Harvard
September 13, 2016
Bryan R. Cullen - Duke University
July, Thursday 14, 2016
Peter Adams - University of Glasgow
June Thursday 16, 2016
Ulrik Ringborg - Karolinska Institute
June 6, 2016
Michail Sitkovsky - Northeastern University
May 03, 2016
Sean Morrison - UT Southwestern
April 07, 2016
Jonathan Weissman - UCSF
Jan 26, 2016
Yasuhiro Yamada: Seminar with Keynote Speaker for the epigenetics@dkfz Workshop
January 14, 2016
Jens Brüning - Max-Planck-Institut
Nov 5, 2015
Michel Nussenzweig - The Rockefeller University
October 2015
Wei Zheng - Vanderbilt University
August 2015
Susan Lindquist - MIT / Whitehead Institute for Biomedical Research
July 2015
Paul Workmann - The Institute of Cancer Research
June 2015
Richard Pestell - Kimmel Cancer Center / Thomas Jefferson University
June 2015
Judith Campisi - Buck Institute
May 2015
Kenneth Anderson - Dana-Farber Cancer Institute
April 2015
Louis Staudt - NIH/NCI
March 2015
Adrian Hayday - London Research Institute
March 2015
Scott A. Armstrong - Memorial Sloan Kettering Cancer Center
February 2015
Reinhard Büttner - Universitätsklinikum Köln
February 2015
Seamus Martin - Trinity College Dublin
February 2015
Toshikazu Ushijima - NCCRI
January 2015
Martin Schwab - ETH Zuerich
December 2014
René Ketting - IBM Mainz
November 2014
Cathrine Wu - Dana Farber / Harvard Cancer Center
October 2014
Peter McKinnon - St. Jude Children's Research Hospital
September 2014
Stefan Hell - Max Planck Institute
September 2014
Yang Shi - Harvard Medical School
September 2014
Laurence Zitvogel - Institut National de la Santé et Recherche Médicale
July 2014
Varda Rotter - Weizmann Institute of Science
July 2014
Vincenzo Bronte - University of Verona
June 03, 2014
Dennis Lo - The Chinese University of Hong Kong
May 09, 2014
Richard Kolodner - Ludwig Institute for Cancer Research, UCSD
April 25, 2014
David A. Williams - Dana Farber Cancer Institute
Mar 18, 2014
Paul Soloway - Cornell University
Jan 23, 2014
Anton Berns - NCI Netherlands
Dec 16, 2013
Johanna Lampe - Fred Hutchinson Cancer Research Center
Dec 4, 2013
Dennis Discher - University of Pennsylvania
Oct 14, 2013
David Spector - Cold Spring Harbor Laboratory
Oct 7, 2013
Rob Wechsler-Reya - Sanford-Burnham Medical Research Institute
Sep 19, 2013
Jim Kaufman - University of Cambridge
July 2, 2013
Ivan Dikic - IBCII
June 24, 2013
George Prendergast - Lankenau Institute for Medical Research
May 13, 2013
Judy Garber - Harvard Medical School
May 6, 2013
Peter Fraser - Babraham Research Campus, Cambridge, UK
April 11, 2013
Giorgio Trinchieri - NIH
March 26, 2013
Marie Hardwick - Johns Hopkins
Feb 15, 2013
Josef Penninger - IMBA, Vienna
Jan 14, 2013
Manel Esteller - University of Barcelona
Jan 11, 2013
Fiona Watt - Cancer Research UK & Kings College London
Nov 21, 2012
Gerard Evan - University of Cambridge
Oct 18, 2012
K.J. Patel - MRC Laboratory of Molecular Biology, Cambridge UK
Sept 19, 2012
Mariano Barbacid - CNIO, Spain
July 17, 2012
Christine Friedenreich - Alberta Health Services & University of Calgary, Canada
July 2, 2012
Gary Gallick - MD Anderson Cancer Center
June 11, 2012
Burkhard Becher - University Hospital of Zurich
June 26, 2012
Mark Rubin - Weill Cornell Medical College
May 21, 2012
Suzanne Ostrand-Rosenberg - University of Maryland, USA
April 17, 2012
Hongjun Song - Johns Hopkins University School of Medicine
April 2, 2012
Helle Ulrich - London Research Institute, Cancer Research UK
February 23, 2012
Rakesh Jain - Harvard
February 21, 2012
Joseph Costello - University of California San Francisco
January 16, 2012
Pier Giuseppe Pelicci - IFOM-IEO Campus, Milano Italy
November 24, 2011
Danny Welch - University of Alabama at Birmingham
July 11, 2011
Dmitry Gabrilovich - H. Lee Moffitt Cancer Center and Research Institute
June 9, 2011
Witold Zatonski - Maria Skłodowska-Curie Memorial Cancer Center, Warsaw
May 9, 2011
Christine Ambrosone - Roswell Park Cancer Institute
April 20, 2011
William Earnshaw - University of Edinburgh
March 1, 2011
Jörn Walter - Universität des Saarlandes
January 17, 2011
11:00 DKFZ Hörsaal
Anne Ridley - Kings College London
September 23, 2010
Jiri Bartek - Research Cancer Institute of Cancer Biology, Copenhagen
June 17, 2010
Michael Taylor - Hospital for Sick Children, Canada
May 28, 2010
Nancy Hynes - Friedrich Miescher Institute (FMI), Switzerland
April 29, 2010
Allan Balmain - Univeristy of California San Francisco, USA
March 24, 2010
Peter Laird - University of Southern California Epigenome Center
February 24, 2010
Benoit Van den Eynde - Ludwig Institute for Cancer Research, Belgium
December 2, 2009
Roberto Cattaneo - Mayo Clinic, USA
November 18, 2009
Erich Nigg - Biozentrum, University of Basel
October 22, 2009
Ewan Birney - European Bioinformatics Institute (EMBL)
July 23 2009
Irving Weissman - Stanford University
June 10 2009
Tom Rapoport - Harvard Medical School & HHMI
April 27 2009
Stephan Beck - University College London Cancer Institute
March 9 2009
Susan Gasser - Friedrich Miescher Institute, Basel
Feb. 19 2009